President Donald Trump is using national security as a justification to implement steep pharmaceutical tariffs on drugs imported from other countries to pressure companies to lower domestic drug prices and boost United States production.
Trump signed an executive order on Thursday afternoon imposing 100% tariffs on patented pharmaceutical products and active pharmaceutical ingredients imported from all but five countries as a means to incentivize drugmakers to lower their U.S. prices and onshore their production facilities.
The policy is intended to not only increase U.S. manufacturing of critical pharmaceutical products but also to advance Trump’s Most Favored Nation drug pricing program, which is intended to lower U.S. prices for prescriptions to match the lowest price paid in similar markets.
Most Favored Nation drug pricing has been the crown jewel of the Trump administration’s efforts to lower healthcare costs for U.S. patients, which are some of the highest in the world.
A senior administration
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!